An isogenic panel of single <i>App</i> knock-in mouse models of Alzheimer’s disease confers differential profiles of β-secretase inhibition and endosomal abnormalities
Naoto Watamura(UK Dementia Research Institute), Hiroki Sasaguri(RIKEN Center for Brain Science), Takaomi C. Saido(RIKEN Center for Brain Science), Shoko Hashimoto(Shiga University of Medical Science), Toshio Ohshima(Waseda University), Mika Takahashi(RIKEN Center for Brain Science), Ayami Iwasaki(Yamaguchi University), Gen Shiihashi(Keio University), Kenichi Nagata(Nagoya University), Naoko Kamano(RIKEN Center for Brain Science), Misaki Sekiguchi(RIKEN Center for Brain Science), Naomi Yamazaki(RIKEN Center for Brain Science), Ryo Fujioka(RIKEN Center for Brain Science), Kaori Sato(Gunma University), Takashi Saito(Nagoya City University)
Cited by 1
Related Papers
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
|Proceedings of the National Academy of Sciences|1996|900
<scp>APP</scp> mouse models for Alzheimer's disease preclinical studies
|The EMBO Journal|2017|780
A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin.
|Journal of Biological Chemistry|1990|429